21.04.2016 18:30:00
|
Deinove Selected to Join the Tech 40 Label
Regulatory News:
DEINOVE (Paris:ALDEI), a biotech company developing innovative processes for producing biofuels and bio-based chemicals by using Deinococcus bacteria, announced today that it had been selected from among 330 listed European high technology securities to join the Tech 40 Label and the corresponding stock market index, EnterNext Tech 40.
The "Tech 40” label, an initiative launched by EnterNext, brings together emblematic companies in the Tech sector listed on the Euronext markets (Amsterdam, Brussels, Lisbon and Paris) and working in life sciences, eco-industries and TMT. The 40 companies receiving the label in 2016 were chosen by a group of independent European experts on the basis of economic, financial and stockmarket performance.
With this label, Deinove will enjoy one year of promotion and special assistance aimed at raising its visibility in the market, notably through a roadshow program targeting European and international investors.
"We are proud to be included in the European Tech 40 label, which groups together companies that are references in their fields and have strong potential in the technology sector,” said Emmanuel Petiot, CEO of Deinove. "This label, which promotes the innovative nature of our activity, will also enable us to increase our visibility among international investors.”
About EnterNext
Launched in May 2013, EnterNext is the subsidiary of the Euronext Group
designed to develop and promote its stock markets specifically for small
and medium-size enterprises (SMEs). Drawing on its pan-European
presence, EnterNext brings together all Euronext Group initiatives for
companies with market capitalizations under €1 billion, including
companies listed in the B and C compartments of its regulated European
markets and on Alternext, the market tailored to the needs of SMEs.
EnterNext
plays an active role in facilitating SMEs' access to financial markets,
helping them generate the funds they need to grow at regional, national
and pan-European level.
About DEINOVE
DEINOVE (Alternext Paris: ALDEI) is ushering in a new era of green
chemistry by designing and developing new standards of production based
on bacteria of untapped potential: the Deinococci. Taking
advantage of the bacteria’s unique genetic properties and unusual
robustness, DEINOVE optimizes natural fermentation and metabolic
capabilities of these bacterial "micro-factories" to produce high
value-added products from non-food biomass. The Company’s primary
markets are 2nd-generation biofuels (DEINOL) and bio-based chemicals
(DEINOCHEM). On these markets, the Company offers its technology to
industrial partners globally.
Listed on NYSE Alternext since April
2010, DEINOVE was founded by Dr. Philippe Pouletty, General Partner of
TRUFFLE CAPITAL, and Pr. Miroslav Radman, of the Faculty of Medicine of
Paris Descartes University. The company employs 50 people in its offices
and laboratories located in Montpellier, France.
More
information at www.deinove.com
View source version on businesswire.com: http://www.businesswire.com/news/home/20160421006128/en/
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu DEINOVE SAmehr Nachrichten
Keine Nachrichten verfügbar. |
Analysen zu DEINOVE SAmehr Analysen
Aktien in diesem Artikel
DEINOVE SA | 0,00 | -99,00% |